JP7700399B1 - 単一の軸不斉化合物の選択的製造法 - Google Patents

単一の軸不斉化合物の選択的製造法 Download PDF

Info

Publication number
JP7700399B1
JP7700399B1 JP2025523047A JP2025523047A JP7700399B1 JP 7700399 B1 JP7700399 B1 JP 7700399B1 JP 2025523047 A JP2025523047 A JP 2025523047A JP 2025523047 A JP2025523047 A JP 2025523047A JP 7700399 B1 JP7700399 B1 JP 7700399B1
Authority
JP
Japan
Prior art keywords
compound
formula
group
salt
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2025523047A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2025053242A5 (https=
JPWO2025053242A1 (https=
Inventor
友博 吉成
直 ▲今▼田
裕貴 石岡
賢一 川口
英次 河南
遵平 大▲高▼
広瀬 勇樹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of JPWO2025053242A1 publication Critical patent/JPWO2025053242A1/ja
Application granted granted Critical
Publication of JP7700399B1 publication Critical patent/JP7700399B1/ja
Publication of JPWO2025053242A5 publication Critical patent/JPWO2025053242A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2025523047A 2023-09-08 2024-09-06 単一の軸不斉化合物の選択的製造法 Active JP7700399B1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP2023/032816 WO2025052649A1 (ja) 2023-09-08 2023-09-08 単一の軸不斉化合物の選択的製造法
JPPCT/JP2023/032816 2023-09-08
PCT/JP2024/031959 WO2025053242A1 (ja) 2023-09-08 2024-09-06 単一の軸不斉化合物の選択的製造法

Publications (3)

Publication Number Publication Date
JPWO2025053242A1 JPWO2025053242A1 (https=) 2025-03-13
JP7700399B1 true JP7700399B1 (ja) 2025-06-30
JPWO2025053242A5 JPWO2025053242A5 (https=) 2025-08-13

Family

ID=94923286

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025523047A Active JP7700399B1 (ja) 2023-09-08 2024-09-06 単一の軸不斉化合物の選択的製造法

Country Status (6)

Country Link
JP (1) JP7700399B1 (https=)
CN (1) CN121843933A (https=)
AU (1) AU2024337896A1 (https=)
CO (1) CO2026004110A2 (https=)
TW (1) TW202527939A (https=)
WO (2) WO2025052649A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018143315A1 (ja) * 2017-02-02 2018-08-09 アステラス製薬株式会社 キナゾリン化合物
WO2022173032A1 (ja) * 2021-02-15 2022-08-18 アステラス製薬株式会社 G12d変異krasタンパクの分解を誘導するためのキナゾリン化合物
WO2022173033A1 (ja) * 2021-02-15 2022-08-18 アステラス製薬株式会社 4-アミノキナゾリン化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023231912A1 (en) * 2022-03-11 2024-08-15 Astellas Pharma Inc. Heterocyclic compound for inducing degradation of g12d mutant kras protein
TW202409002A (zh) * 2022-07-21 2024-03-01 日商安斯泰來製藥股份有限公司 作用於g12d突變kras蛋白之雜環化合物
CN119630656A (zh) * 2022-08-05 2025-03-14 安斯泰来制药株式会社 用于诱导突变kras蛋白分解的杂环化合物
WO2024034593A1 (ja) * 2022-08-09 2024-02-15 アステラス製薬株式会社 G12v変異krasタンパクの分解を誘導するための複素環化合物
TW202412790A (zh) * 2022-08-09 2024-04-01 日商安斯泰來製藥股份有限公司 用於抑制及/或誘導分解kras蛋白之雜環化合物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018143315A1 (ja) * 2017-02-02 2018-08-09 アステラス製薬株式会社 キナゾリン化合物
JP6587116B2 (ja) * 2017-02-02 2019-10-09 アステラス製薬株式会社 キナゾリン化合物
WO2022173032A1 (ja) * 2021-02-15 2022-08-18 アステラス製薬株式会社 G12d変異krasタンパクの分解を誘導するためのキナゾリン化合物
WO2022173033A1 (ja) * 2021-02-15 2022-08-18 アステラス製薬株式会社 4-アミノキナゾリン化合物

Also Published As

Publication number Publication date
WO2025052649A1 (ja) 2025-03-13
AU2024337896A1 (en) 2026-03-19
WO2025053242A1 (ja) 2025-03-13
TW202527939A (zh) 2025-07-16
CN121843933A (zh) 2026-04-10
CO2026004110A2 (es) 2026-04-16
JPWO2025053242A1 (https=) 2025-03-13

Similar Documents

Publication Publication Date Title
BR112020018562A2 (pt) Processo preparativo
TWI750685B (zh) 二取代吡唑化合物
HK1248702A1 (zh) 取代的吡咯烷-2-甲酰胺
KR20010014658A (ko) 항암 화합물의 제조 방법 및 중간체
JP5603998B2 (ja) ベンゾオキサボロールの調製方法
US12077528B2 (en) Preparation method for deuterated macrocyclic compound
CN120418252A (zh) Malt1抑制剂
AU2021219097A1 (en) P2X3 modulators
CN115151529B (zh) 用于制备乌帕替尼的方法和中间体
CN116507601A (zh) 制备3-氟-5-(((1S,2aR)-1,3,3,4,4-五氟-2a-羟基-2,2a,3,4-四氢-1H-环戊[cd]茚-7-基)氧基)苯甲腈的方法
CN113039178A (zh) 吡啶并[2,3-d]嘧啶-7(8H)-酮的合成
EP2168952A1 (en) Morpholine derivative
JP2009529045A (ja) 7−アルキニル−4−アミノキナゾリンを合成する方法及び関連した中間体
JP2006527769A (ja) Cb1モジュレーターとしての2,3位置換5,6−ジアリール−ピラジン誘導体
EP2444393A1 (en) Methods for producing cyclic benzamidine derivatives
JP7700399B1 (ja) 単一の軸不斉化合物の選択的製造法
EP4472982A1 (en) Processes for the preparation of selective estrogen receptor degraders
CN107531680B (zh) 一种毒素及其中间体的制备方法
CN121487934A (zh) 能够用于治疗smarca4缺失型癌症的作为smarca2抑制剂的1.6-萘啶化合物
CN121443603A (zh) 能够用于治疗smarca4缺失型癌症的作为smarca2抑制剂的1,6-萘啶化合物
JP2025510230A (ja) Shp2阻害剤の調製プロセス
JP2017081832A (ja) トリアジンジオン化合物
US20240199629A1 (en) Processes for the preparation of selective estrogen receptor degraders
CA3214107A1 (en) New process for the synthesis of 5-{5-chloro-2-[(3s)-3- [(morpholin-4-yl)methyl]-3,4-dihydroisoquinoline-2(1h)- carbonyl]phenyl}-1,2-dimethyl-1h-pyrrole-3-carboxylic acid derivatives and its application for the production of pharmaceutical compounds
BR122025017416A2 (pt) Compostos degradadores seletivos de receptores de estrogênio

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250422

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250422

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20250422

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250613

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250618

R150 Certificate of patent or registration of utility model

Ref document number: 7700399

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150